
MRNA vs EXEL
$MRNA vs $EXEL head to head: price, market cap, valuation, dividend, free float, relative volume and how actively each trades. The bigger value in the size rows is bolded. Tap either ticker for its live chart, full ownership breakdown and real-time alerts.
MRNA vs EXEL: the quick read
- ·MRNA is the larger company by market cap ($61.50B vs $14.46B).
- ·MRNA has been more active on our scanner (335 vs 99 alerts in 30 days).
- ·EXEL has the smaller float (228.6M vs 354.9M), which tends to mean sharper, more volatile moves.
- ·Both are biological products, (no diagnostic substances) names, so this is a like-for-like comparison and sector news tends to move them together.
- ·MRNA draws far more of our scanner's attention, 335 unusual-volume alerts in 30 days against 99, so it is the more actively traded of the two by some distance.
- ·Both are trading in the upper quarter of their 52-week range, so neither is a pullback candidate right now.
- ·EXEL is the one in play today, trading about 2.2x its normal volume, which is what puts a name on our scanner in the first place.
Objective differences only. Not investment advice.
Get the best catches in your inbox
Free daily email of the top plays and unusual-volume alerts our scanner flags. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Frequently asked questions
Everything you need to know comparing MRNA and EXEL on TheDesperateTrader.
- Is MRNA or EXEL the better stock?
- "Better" depends on your goal, and these two are not alike. MRNA is the larger company by market cap ($61.50B vs $14.46B). MRNA has been more active on our scanner (335 vs 99 alerts in 30 days). EXEL has the smaller float (228.6M vs 354.9M), which tends to mean sharper, more volatile moves. Those are the measured differences, not a recommendation, and nothing here is investment advice.
- What is the difference between MRNA and EXEL?
- The differences that matter: MRNA is roughly 4x the size of the other by market cap ($61.50B vs $14.46B); they trade at very different share prices ($153.87 vs $58.84); MRNA sits at 85% of its 52-week range against 97% for EXEL; our scanner flagged MRNA 335 times in the last 30 days against 99 for EXEL. Everything above is measured from the latest completed session and SEC filings.
- Which of MRNA and EXEL is more active right now?
- Right now MRNA is at about 0.8x its normal volume and EXEL is at about 2.2x, so EXEL is the one drawing unusual attention today. Relative volume (RVOL) compares a stock's volume to its own recent average, so it reads the same way for a megacap and a microcap and is the quickest way to tell which of two similar names is actually in play.
- Is this comparison data live?
- Prices and % changes are anchored to the latest completed session and split-adjusted, so a reverse split never shows as a fake move. Float is estimated from SEC filings and refreshed as new filings publish.
Trading MRNA or EXEL? Get real-time unusual-volume alerts the moment either one moves, free.
No card · 5 premium daysMore MRNA and EXEL comparisons
Same sector, similar size. These are the peers each one is usually weighed against.
Explore the market
Free, live market tools. No account required to look.